AstraZeneca’s Tezspire Shows Promise in Phase III Trial
AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Tezspire has shown promising results in the Phase III WAYPOINT trial, ...
AstraZeneca: Navigating Challenges with Long-Term Growth Confidence Supports Buy Rating
Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...
Hosted on MSN4d
Indian 'vaccine prince' becomes owner of 'London's most expensive home' this year after paying £138million for Mayfair mansion
In 2021, the family pledged £50million to Oxford university for a new Poonawalla Vaccines Research Building, having manufactured hundreds of millions of doses of the Oxford/AstraZeneca vaccine.
AstraZeneca's China chief in custody, believes unrelated to insurance probe
AstraZeneca said on Wednesday its China president Leon Wang had been detained by Chinese authorities and, although it did not ...